Greenphire
↗King of Prussia, USA
Greenphire is a leading provider of global clinical trial financial lifecycle management software. The company's platform automates payment and logistical workflows between sponsors, contract research organizations (CROs), research sites, and study participants, aiming to improve trial performance, participant retention, and financial transparency.
In January 2025, Greenphire merged with Suvoda LLC, a global clinical trial technology company. The combined entity continues to provide specialized software solutions for clinical trial management, including budgeting, benchmarking, and site payment automation.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Clinical Trial Management Software
SIZE & FINANCIALS
Employees:201-500
Revenue:$100M-$250M
Founded:2008
Ownership:subsidiary
Status:merged
FUNDING
Total Raised:$5.8M
Investors:Thoma Bravo, The Riverside Company, FirstMark Capital, Ben Franklin Technology Partners
0
CORPORATE STRUCTURE
Parent Company:Suvoda LLC
Acquired By:Suvoda LLC (2025-01-01)
Key Partnerships:Top 30 Pharmaceutical Companies, Top 10 CROs
COMPETITION
Position:Leader
Competitors:Clario, Cytel, Celeritas Solutions
LEADERSHIP
Key Executives:
Jim Murphy - CEO
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Greenphire and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Greenphire. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.